PuSH - Publikationsserver des Helmholtz Zentrums München

Mainz, A.* ; Peschek, J.* ; Stavropoulou, M.* ; Back, K.C.* ; Bardiaux, B.* ; Asami, S.* ; Prade, E.* ; Peters, C.* ; Weinkauf, S.* ; Buchner, J.* ; Reif, B.

The  chaperone αB-crystallin uses different interfaces to capture an amorphous and an amyloid client

Nat. Struct. Mol. Biol. 22, 898-905 (2015)
Verlagsversion DOI PMC
Open Access Gold
Small heat-shock proteins, including αB-crystallin (αB), play an important part in protein homeostasis, because their ATP-independent chaperone activity inhibits uncontrolled protein aggregation. Mechanistic details of human αB, particularly in its client-bound state, have been elusive so far, owing to the high molecular weight and the heterogeneity of these complexes. Here we provide structural insights into this highly dynamic assembly and show, by using state-of-the-art NMR spectroscopy, that the αB complex is assembled from asymmetric building blocks. Interaction studies demonstrated that the fibril-forming Alzheimer's disease Aβ1-40 peptide preferentially binds to a hydrophobic edge of the central β-sandwich of αB. In contrast, the amorphously aggregating client lysozyme is captured by the partially disordered N-terminal domain of αB. We suggest that αB uses its inherent structural plasticity to expose distinct binding interfaces and thus interact with a wide range of structurally variable clients.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
13.309
2.403
86
92
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Sprache englisch
Veröffentlichungsjahr 2015
HGF-Berichtsjahr 2015
ISSN (print) / ISBN 1545-9993
e-ISSN 1545-9985
Quellenangaben Band: 22, Heft: 11, Seiten: 898-905 Artikelnummer: , Supplement: ,
Verlag Nature Publishing Group
Verlagsort New York, NY
Begutachtungsstatus Peer reviewed
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Enabling and Novel Technologies
PSP-Element(e) G-503090-001
PubMed ID 26458046
Scopus ID 84948073235
Erfassungsdatum 2015-10-21